Abstract
Bone marrow cells from patients with light chain deposition disease (LCDD) or primary or myeloma amyloidosis were studied by immunofluorescence and biosynthesis experiments after incorporation of radioactive aminoacids. Monoclonal plasma cell populations were demonstrated even in patients without serum and urine monoclonal immunoglobulins and with a normal percentage of plasma cells. Structurally abnormal immunoglobulins were produced in several LCDD patients: abnormal light chains (by their short or large size, glycosylation and polymerization in vivo and in vitro) and abnormal (short) heavy chains. In other cases, light chains were normal sized and unglycosylated but they also showed a strong tendency to polymerize. The secretion of free light chains featured every amyloidosis case and the presence of light chain fragments almost all cases. Additional features in amyloidosis were synthesis of short γ chains (two cases), assembly block at the HL half molecule level of a monoclonal IgA (one case) and secretion of decameric enlarged k chains (one case). This is in contrast with non-myelomatous secondary amyloidosis where the distribution of bone marrow plasma cells was normal by immunofluorescence and where normal sized immunoglobulins were synthesised, without free light chain secretion and fragments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zolla S, Franklin EC, Scharff MD. Synthesis and assembly of immunoglobulins by malignant human plasmacytes. I. Myeloma producing γ-chains and light chains. J Exp Med 1970; 132: 148–57.
Preud’homme JL, Labaume S. Detection of surface immunoglobulins on human cells by direct immunofluorescence. In: Bloom BR, David JR, eds. In vitro Methods in Cell-Mediated and Tumor Immunity, New York: Academic Press, 1976; 155–169.
Preud’homme JL, Birshtein BK, Scharff MD. Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype. Proc Nat Acad Sci USA 1975; 72: 1427–30.
Preud’homme JL, Klein M, Labaume S, Seligmann M. Idiotype-bearing and antigen- binding receptors produced by blood T lymphocytes in a case of human myeloma. Europ J Immunol 1977; 7: 840–6.
Preud’homme JL, Labaume S, Praloran V. Synthesis of abnormal heavy chains in Bence Jones plasma cell leukemia with intracellular IgG. Blood 1980; 56: 1136–40.
Preud’homme JL, Morel-Maroger L, Brouet JC, Cerf M, Mignon F, Guglielmi P, Seligmann M. Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition. Amer J Med 1980; 69: 703–10.
Preud’homme JL, Morel-Maroger L, Brouet JC, Mihaesco E, Mery JP, Seligmann M. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol 1980; 42: 545–53.
Preud’homme JL, Mihaesco E, Gugliemi P, Morel-Maroger L, Ganeval D, Danon F, Brouet JC, Mihaesco C, Seligmann M. La maladie des dépôts de chaines légères ou d’immunoglobulines monoclonales: concepts physiopathogéniques, Nouv Presse Med 1982; 11:3259–63.
Ganeval D, Mignon F, Preud’homme JL, Noel LH, Morel-Maroger L, Droz D, Brouet JC, Mery JP, Grunfeld JP. Visceral deposition of monoclonal light chains and immunoglobulins: a study of renal and immunopathologic abnormalities. In: Hamburger J, Crosnier J, Grünfeld JP, Maxwell MH, eds. Advances in Nephrology, Year Book Medical Publ 1982; 11:25–63.
Ganeval D, Noel LH, Preud’homme JL, Droz D, Grunfeld JP. Light chain deposition disease. Its relation with AL-type amyloidosis. Kidney Internat 1984; 26: 1–9.
Preud’homme JL, Buxbaum J, Scharff MD. Mutagenesis of mouse myeloma cells with Melphalan. Nature 1973; 245: 320–2.
Osserman EF, Takatsuki K, Talal N. The pathogenesis of ‘amyloidosis’. Studies on the role of abnormal gammaglobulin fragments of the Bence Jones (L-polypeptide) type in the pathogenesis of ‘primary’ and ‘secondary amyloidosis’ and the ‘amyloidosis’ associated with plasma cell myeloma. Semin Hematol 1964; 1: 33–85.
Preud’homme JL, Hurez D, Danon F, Brouet JC, Seligmann M. Intracytoplasmic and surface bound immunoglobulins in ‘nonsecretory’ and Bence-Jones myeloma. Clin Exp Immunol 1976; 25: 428–36.
Preud’homme JL, Danon F, Hurez D, Brouet JC, Seligmann M. Myélomes sans immunoglobuline monoclonale sérique ni urinaire (myélomes dits non excrétants). Actual Hématol 1977; 11: 213–9.
15.Preud’homme JL, Seligmann M. Human lymphoplasmacytic proliferations with production of structurally abnormal immunoglobulins. In: Dixon FJ, Miescher PA, eds. Immunopathology, VHIth International Symposium. New York: Academic Press, 1982: 331–44.
Sox HC, Hood L. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. Proc Natl Acad Sci 1970; 66: 975–82.
Spiegelberg HL, Abel CA, Fishkin BG, Grey HM. Localization of the carbohydrate within the variable region of light and heavy chains of human γ G myeloma proteins. Biochemistry 1970; 9: 4217–23.
Soiling K, Askjaer SA. Multiple myeloma with urinary excretion of heavy chain components of IgG and nodular glomerulosclerosis. Acta Med Scand 1973; 194: 23–9.
Gallo GR, Feiner HD, Buxbaum JN. The kidney in lymphoplasmocytic disorders. In: Sommers SC, Rosen PP, eds. Pathology Annual. Norwalk Connecticut: ACC (Appleton-Century-Crofts), 1982: 17 (part 1), 291–317.
Gallo GR, Feiner HD, Katz LA, Feldman GM, Correa E, Chuba JV, Buxbaum JN. Nodular glomerulopathy associated with non amyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis. Am J Pathol 1980; 99: 621–44.
Buxbaum J. Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture. J Clin Invest 1986; 78: 798–806.
Glenner GG, Ein D, Eanes ED, Bladen HA, Terry W, Page DL. Creation of ‘amyloid’ fibrils from Bence Jones proteins in vitro. Science 1971; 174: 712–4.
Linke RP, Zucker-Franklin D, Franklin EC. The formation of amyloid-like fibrils in vitro from Bence-Jones proteins of the V λ 1 subclass. J Immunol 1973; 111: 24–6.
Epstein WV, Tan M, Wood IS. Formation of amyloid fibrils in vitro by action of human kidney lysosomal enzymes in Bence-Jones proteins. J Lab Clin Med 1974; 84: 107–10.
Glenner GG. Amyloid deposits and amyloidosis: the γ-fibrillose. N Engl J Med 1980; 302: 1283–93, 1333–43.
Durie BGM, Persky B, Soehnlen BJ, Grogan TM, Salmon SE. Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages. N Engl J Med 1982; 307: 1689–92.
Buxbaum JN, Hurley ME, Chuba J, Spiro T. Amyloidosis of the AL type. Clinical, morphologic and biochemical aspects of the response to therapy with alkylating agents and prednisone. Am J Med 1979; 67: 867–78.
Jacquot C, Saint-And ré JP, Touchard G, Nochy D, D’Auzac de Lamartinie C, Oriol R, Druet P, Bariety J. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement. Clin Nephrol 1985; 24: 93–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers, Dordrecht
About this chapter
Cite this chapter
Preud’Homme, JL. (1988). Immunoglobulin synthesis in plasma cell dyscrasias with renal lesions. In: Minetti, L., D’Amico, G., Ponticelli, C. (eds) The Kidney in Plasma Cell Dyscrasias. Developments in Nephrology, vol 22. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1315-8_3
Download citation
DOI: https://doi.org/10.1007/978-94-009-1315-8_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7085-0
Online ISBN: 978-94-009-1315-8
eBook Packages: Springer Book Archive